P Petera

Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide

Frédéric Houssiau, Carlos Vasconcelos, David D’Cruz et al. · Arthritis & Rheumatism · 2002 · 1.1K citations · Full text

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

Frédéric Houssiau, Carlos Vasconcelos, D. D’Cruz et al. · Annals of the Rheumatic Diseases · 2009 · 528 citations

Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long‐term followup of patients in the Euro‐Lupus Nephritis Trial

Frédéric Houssiau, Carlos Vasconcelos, David D’Cruz et al. · Arthritis & Rheumatism · 2004 · 382 citations · Full text

TUMOUR NECROSIS FACTOR ALPHA AND ITS SOLUBLE RECEPTORS PARALLEL CLINICAL DISEASE AND AUTOIMMUNE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS

A Studnicka-Benke, G Steiner, P Petera et al. · Lara D. Veeken · 1995 · 280 citations · Full text

Immunology, Pathology, Tnf System +18

Modulation of the migration and chemotaxis of PMN cells by hyaluronic acid.

G Partsch, C Schwarzer, Josef Neumüller et al. · PubMed · 1989 · 56 citations